Stegbauer et al. [29] demonstrated that senescent CD8+ T cells (CD28−CD57+) independently predicted adverse outcomes, including stroke, heart failure hospitalization, and cardiovascular death, particularly in patients stratified by CHA2DS2-VASc score. The gene discussed is CD8A; the disease is stroke disorder.